Providing independent clinical excellence since 2005
Posted on Monday September 2, 2024 in News
It seemed important to spread some of our medically verified opinions to help counter fake or misleading health stories found on the internet.
With over 50 blog articles published, the editorial team had sufficient material of general interest to feature a weekly story by mailshot.
We therefore developed an official mailing list, including an all important ‘unsubscribe’ option, for those that would rather not be sent these notifications.
2025
| Download issue 5 |  |  |
2024
| Download issue 4 |  |  |
| Download Issue 3 |  |  |
| Download Issue 2 |  |  |
| Download Issue 1 | |  |
Cardiovascular disease is detectable and treatable decades before first symptoms appear, especially in the critical age range known as *"Sniper’s Alley"* (40–60 years). Waiting until 60 is too late. Early prevention, particularly LDL cholesterol control, saves lives. Learn why men and women with a family history of heart disease demands a more proactive approach — and why starting young matters.
When clots from the left atrial appendage dislodge, they can travel to various parts of the body, including the coronary artery, which receives about 5% of the blood from each heartbeat, or the cerebral arteries, accounting for approximately 20% of each cardiac cycle's output
This article looks into the role of PCSK9, the development of PCSK9 inhibitors, their efficiency, and their potential as a game-changer in the management of cardiovascular diseases. It provides a short exploration of the subject, drawing upon the most recent and relevant research and guidelines.
For patients who have been diagnosed with an acute coronary syndrome, requiring bypass surgery or stent, or have CT Angiography and or raised FAI, the latest European and UK guidelines reflect the finding that there is no lower limit for LDL yet discovered, basically meaning the lower the better. These recommendations come after new trials with lower targets showed better outcomes. As a result, millions of people around the world need to be looking more carefully at whether they are taking sufficient medication to lower their LDL to these new targets, for the very best outcomes to be achieved.